1. Lurasidone in Schizophrenia: New Information About Dosage and Place in Therapy

   • Leslie Citrome

   Review 20 September 2012 Pages: 815 - 825

2. Post-Marketing Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir: An Updated Review

   • Stephen Toovey
   • Eric P. Prinssen
   • Barbara Donner

   Review Open access 02 October 2012 Pages: 826 - 848

3. Opioid Rotation in Clinical Practice

   • Srinivas R. Nalamachu

   Review 25 September 2012 Pages: 849 - 863

4. Endoscopic Tattooing of Gastrointestinal and Pancreatic Lesions

   • Carmelo Luigiano
   • Francesco Ferrara
   • Pierluigi Consolo

   Review 05 October 2012 Pages: 864 - 873

5. Corneal Epithelial Cell Viability Following Exposure to Ophthalmic Solutions Containing Preservatives and/or Antihypertensive Agents

   • Jess T. Whitson
   • W. Matthew Petroll

   Original Research 10 October 2012 Pages: 874 - 888

6. Pharmacokinetics of Empagliflozin, a Sodium Glucose Cotransporter-2 (SGLT-2) Inhibitor, Coadministered with Sitagliptin in Healthy Volunteers

   • Tobias Brand
   • Sreeraj Macha
   • Hans J. Woerle

   Original Research 01 October 2012 Pages: 889 - 899

7. Post-Stroke Pneumonia Prevention by Angiotensin-Converting Enzyme Inhibitors: Results of a Meta-analysis of Five Studies in Asians

   • Yukito Shinohara
   • Hideki Origasa

   Original Research 14 September 2012 Pages: 900 - 912

8. Per-Attack Reporting of Prodromal Symptoms Concurrent with C1-Inhibitor Treatment of Hereditary Angioedema Attacks

   • Michael J. Prematta
   • Againdra K. Bewtra
   • Timothy J. Craig

   Original Research 27 September 2012 Pages: 913 - 922

9. Erratum to: Shockwave Therapy in Patients with Peripheral Artery Disease

   • Marco Matteo Ciccone
   • Angela Notarnicola
   • Biagio Moretti

   Erratum 02 September 2012 Pages: 923 - 923